- AutorIn
- Maria Neumann Technische Universität Dresden, Work Group Addictive Behaviors, Risk Analysis and Risk Management, Dresden, Germany
- Gerhard BühringerTechnische Universität Dresden, Work Group Addictive Behaviors, Risk Analysis and Risk Management, Dresden, Germany
- Michael HöflerTechnische Universität Dresden, Work Group Addictive Behaviors, Risk Analysis and Risk Management, Dresden, Germany
- Hans-Ulrich Wittchen
- Eva Hoch
- Titel
- Is Cannabis Use Treatment Also Indicated for Patients with Low to Moderate Polysubstance Use?
- Zitierfähige Url:
- https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa2-706474
- Quellenangabe
- European addiction research Erscheinungsort: Basel
Verlag: Karger
Erscheinungsjahr: 2018
Jahrgang: 24
Heft: 2
Seiten: 79-87
ISSN: 1022-6877
E-ISSN: 1421-9891 - Erstveröffentlichung
- 2018
- Abstract (EN)
- Background: Polysubstance use (PSU) is common among patients with cannabis use (CU) and is related to more severe CU problems. However, it is unclear how PSU predicts CU treatment outcomes beyond CU patterns. We examined the frequency, amount, and class of additionally used substances as predictors for primary and secondary outcomes. Methods: We conducted crude and adjusted regression analyses for PSU variables as predictors of remission, abstinence, reduction, and secondary outcomes in 166 help-seeking patients from a randomized clinical trial of CANDIS, a cognitive behavioral treatment program. Results: Patients with recent illegal PSU experienced more difficulties in reducing their CU (B = –1.22, p < 0.001). In contrast, remission rates were slightly higher in patients with a wide variety of last-year-PSU (RD = 0.04, p < 0.001). Amphetamine use predicted poorer outcomes regarding CU-related problems (B = –4.22, p = 0.019), and the use of opiates, inhalants, and dissociative substances predicted poorer physical health outcomes (B = –0.62, p = 0.009; B = –0.96, p = 0.039; B = –1.18, p = 0.007). Conclusions: CU treatment is also effective for patients with moderate PSU. However, treatment effects may be enhanced by addressing specific PSU characteristics as part of a modularized program.
- Andere Ausgabe
- Link zum Artikel der zuerst in der Zeitschrift 'European addiction research' erschienen ist
DOI: 10.1159/000488345 - Freie Schlagwörter (DE)
- Störung des Cannabiskonsums, Behandlungsergebnis, Primär- und Sekundärergebnisse, Prädiktoren, Polysubstanz-Konsum, CANDIS
- Freie Schlagwörter (EN)
- Cannabis use disorder, Treatment outcome, Primary and secondary outcomes, Predictors, Polysubstance use, CANDIS
- Klassifikation (DDC)
- 610
- 150
- Verlag
- Karger, Basel
- Förder- / Projektangaben
- German Federal Ministry of Health
CANnabis DISordersID: NCT00673647
European Community’s Seventh Framework ProgrammeFP7/2007-2013
ID: 266813 - Version / Begutachtungsstatus
- publizierte Version / Verlagsversion
- URN Qucosa
- urn:nbn:de:bsz:14-qucosa2-706474
- Veröffentlichungsdatum Qucosa
- 26.05.2020
- Dokumenttyp
- Artikel
- Sprache des Dokumentes
- Englisch
- Lizenz / Rechtehinweis